
Agilent Technologies A
$ 116.23
0.6%
Quarterly report 2025-Q4
added 03-03-2026
Agilent Technologies P/E Ratio 2011-2026 | A
Annual P/E Ratio Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 34.7 | 50.1 | 23.7 | 73.5 | 32.6 | 31 | 34.7 | 28.2 | 18 | 8.27 | 9.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 73.5 | 8.27 | 31.3 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
-0.125 | $ 1.67 | - | $ 2.22 M | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 25.26 | 3.27 % | $ 702 M | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 21.52 | 1.37 % | $ 1.15 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | ||
|
Illumina
ILMN
|
-13.4 | $ 127.89 | 0.01 % | $ 20.3 B | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 16.19 | -0.74 % | $ 490 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 172.96 | 1.88 % | $ 8.57 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
Guardant Health
GH
|
-32.3 | $ 90.69 | 2.0 % | $ 11.4 B | ||
|
Lantheus Holdings
LNTH
|
21.9 | $ 84.36 | 0.04 % | $ 5.69 B | ||
|
Medpace Holdings
MEDP
|
28.7 | $ 416.53 | 1.46 % | $ 12 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
0.299 | $ 2.0 | 1.27 % | $ 8.85 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 27.72 | 0.91 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Senseonics Holdings
SENS
|
-5.07 | $ 7.07 | 0.21 % | $ 295 M | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 9.6 | 0.58 % | $ 2.08 B | ||
|
Soleno Therapeutics
SLNO
|
99.7 | $ 52.74 | 0.04 % | $ 2.68 B | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.17 | 1.4 % | $ 4.98 M | ||
|
National Research Corporation
NRC
|
27.2 | $ 17.26 | 0.17 % | $ 386 M | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 102.05 | -0.12 % | $ 8.42 B | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 265.38 | 0.62 % | $ 22.1 B | ||
|
Thermo Fisher Scientific
TMO
|
29.3 | $ 470.88 | 0.28 % | $ 178 B | ||
|
Celcuity
CELC
|
-30.3 | $ 125.51 | 3.7 % | $ 5.87 B | ||
|
Trinity Biotech plc
TRIB
|
129 | $ 0.65 | 0.03 % | $ 61.9 M | ||
|
OpGen
OPGN
|
0.761 | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
-13.7 | $ 8.43 | 1.69 % | $ 1.08 B | ||
|
Twist Bioscience Corporation
TWST
|
-20.1 | $ 60.75 | -0.31 % | $ 3.63 B | ||
|
Myriad Genetics
MYGN
|
-1.12 | $ 4.79 | 0.1 % | $ 444 M | ||
|
Natera
NTRA
|
-9.69 | $ 206.25 | 1.23 % | $ 20.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
23.5 | $ 197.24 | 0.52 % | $ 21.9 B | ||
|
Invitae Corporation
NVTA
|
-5.12 | - | - | $ 21.2 M | ||
|
PerkinElmer
PKI
|
52.3 | - | -0.91 % | $ 14.7 B |